MOSCOW (MRC) -- Evonik and Brenntag agree to cooperate on hydrogen peroxide and peracetic acid for pharma and cosmetics markets, as per the producer's press release.
Evonik Industries is introducing new hydrogen peroxide and peracetic acid grades for drug, medical products, and cosmetics manufacturers in response to increasingly more stringent regulatory requirements in these close-to-consumer industry segments. In Europe, customers will receive tailored solutions, enabling them to provide end consumers with safe and fully certified products.
In addition to their existing product portfolio for the cosmetics industry, Evonik is expanding its spectrum for the pharma industry by offering active pharmaceutical ingredients (APIs) produced on the basis of Good Manufacturing Practice (GMP). As the central point of production, Wei?enstein in Austria is currently being certified according to GMP guidelines. This will make Evonik the first hydrogen peroxide manufacturer in Europe with a fully back integrated production. To date, the site is certified according to ISO 9001, 14001, and 13485.
Brenntag Europe, Middle East and Africa is Evonik’s partner in many European countries for the marketing of hydrogen peroxide and peracetic acid product portfolios in the Personal & Health Care market segment. Product marketing will be launched in the middle of the year, spanning a total of 25 countries in Europe.
As MRC informed earlier, Evonik Industries in June completed the acquisition of Monarch Catalyst (Dombivli, India). All of Evonik’s future catalyst activities in India will be operated through the newly acquired company. Financial details of the transaction have not been disclosed.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world.
MOSCOW (MRC) -- Due to production problems in the hexamethylenediamine (HMD)-plant in Seal Sands (UK), BASF, the world's petrochemical major, has declared force majeure for hexamethylenediamine (HMD), AH salt and polyamide 66 polymer on 16 June 2015, reported the producer on its site.
As a result, BASF is declaring force majeure for polyamide 66 compounds (Ultramid A, Capron PA66) supplied from Europe effective 17 June 2015.
At this stage, the company is not in a position to predict how long the force majeure situation will last. BASF will update the customers on the situation as soon as possible. The company announced this in a press release issued today, 18 June 2015.
As MRC wrote previously, on 11 September 2014, BASF shut its No 1 naphtha cracker for maintenance turnaround. The plant remained off-stream for around one month. Located at Ludwigshafen in Germany, the cracker has a capacity of 220,000 mt/year.
BASF is the leading chemical company. It produces a wide range of chemicals, for example solvents, amines, resins, glues, electronic-grade chemicals, industrial gases, basic petrochemicals and inorganic chemicals. The most important customers for this segment are the pharmaceutical, construction, textile and automotive industries.
MRC
MOSCOW (MRC) -- Rosneft and BP signed several agreements strengthening the long term strategic relationship between the two companies, at the St. Petersburg International Economic Forum, said BP in its press release.
Rosneft and BP signed final binding agreements for Rosneft’s sale to BP of a 20 per cent share of Taas-Yuryakh Neftegazodobycha (Taas), creating a new joint venture in East Siberia. The document was signed by Rosneft Management Board Chairman Igor Sechin and President of BP Russia David Campbell.
The venture will further develop the Srednebotuobinskoye oil and gas condensate field which is one of the largest fields in eastern Siberia, currently producing about 20,000 barrels a day. The Taas venture will also undertake the development of suitable infrastructure for further exploration and development of the region’s reserves. Related to this, Rosneft and BP will also jointly undertake the exploration of an associated Area of Mutual Interest (AMI) in the region, covering approximately 115,000 square kilometres.
Within the framework of the Forum, Igor Sechin and David Campbell also signed a heads of terms to pursue a reorganization of the German Ruhr Oel GmbH (ROG) refining joint venture. The document envisages restructuring the JV by dividing between the parties shares in four refineries and associated infrastructure.
As a result of the planned deal Rosneft will double its shareholding in the Bayernoil refinery – to 25% from 12.5%; the MiRO refinery – to 24% from 12%; and the PCK Raffinerie – to 37.5% from 18.75%.
BP in exchange will consolidate 100% of the equity of the Gelsenkirchen refinery and the solvent production facility DHC Solvent Chemie. The closing of the deal is subject to the fulfillment of conditions precedent, which include inter alia regulatory approvals.
The restructuring of Ruhr Oel GmbH will enable Rosneft and BP to re-focus their refining and petrochemicals strategies in Germany.
In May 2011, Rosneft acquired a 50% share in a joint venture Ruhr Oel GmbH (ROG) in Germany. ROG holds stakes in four refineries in Germany.
Rosneft became Russia's largest publicly traded oil company in March 2013 after the USD55 billion takeover of TNK-BP, which was Russia’s third-largest oil producer at the time.
BP is one of the world's leading international oil and gas companies, providing its customers with fuel for transportation, energy for heat and light, retail services and petrochemicals products for everyday items.
MRC